Maxim Group Has Negative View of Health In Tech Q3 Earnings

Health In Tech, Inc. (NASDAQ:HIT) – Research analysts at Maxim Group dropped their Q3 2026 earnings estimates for shares of Health In Tech in a report issued on Friday, October 2nd. Maxim Group analyst A. Klee now anticipates that the company will post earnings per share of ($0.10) for the quarter, down from their prior forecast of ($0.04). Maxim Group currently has a “Buy” rating and a $3.00 target price on the stock. Maxim Group also issued estimates for Health In Tech’s Q4 2026 earnings at ($0.14) EPS, FY2026 earnings at ($0.31) EPS, Q1 2027 earnings at ($0.05) EPS, Q2 2027 earnings at ($0.06) EPS, Q3 2027 earnings at ($0.06) EPS, Q4 2027 earnings at ($0.09) EPS and FY2027 earnings at ($0.26) EPS.

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Health In Tech in a research report on Friday, September 25th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $3.50.

Health In Tech Stock Performance

Shares of Health In Tech stock opened at $0.76 on Tuesday. The stock has a 50 day moving average of $0.95 and a 200 day moving average of $1.13. The firm has a market capitalization of $49.83 million, a price-to-earnings ratio of -10.86 and a beta of 2.81. Health In Tech has a fifty-two week low of $0.65 and a fifty-two week high of $4.02.

Health In Tech (NASDAQ:HIT) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). The firm had revenue of $8.06 million for the quarter.

Institutional Investors Weigh In On Health In Tech

A hedge fund recently bought a new stake in Health In Tech stock. Whetstone Capital Advisors LLC acquired a new position in Health In Tech, Inc. (NASDAQ:HIT) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,509,766 shares of the company’s stock, valued at approximately $1,525,000. Whetstone Capital Advisors LLC owned about 2.30% of Health In Tech as of its most recent filing with the Securities and Exchange Commission.

Key Stories Impacting Health In Tech

Here are the key news stories impacting Health In Tech this week:

• Positive Sentiment: Maxim Group maintained a Buy rating and a $3.00 price target for Health In Tech, implying substantial upside from recent trading levels. Health In Tech Q3 Earnings Forecast Decreased by Maxim Group
• Neutral Sentiment: Maxim’s updated model projects continued quarterly losses, including estimated EPS of $(0.10) in Q3 2026, $(0.14) in Q4 2026, $(0.05) in Q1 2027, $(0.06) in Q2 and Q3 2027, and $(0.09) in Q4 2027.
• Negative Sentiment: Maxim cut its Q3 2026 EPS forecast to $(0.10) from $(0.04) and reduced its Q4 2026 estimate to $(0.14) from $(0.03), signaling weaker near-term profitability expectations.
• Negative Sentiment: Full-year 2026 EPS expectations were lowered to $(0.31) from $(0.10), while the FY2027 forecast was reduced to $(0.26) from $(0.02). The breadth and size of these cuts are the main bearish catalyst for HIT today.
• Negative Sentiment: The revisions come as Health In Tech remains unprofitable; its latest reported quarter showed a $(0.04) EPS loss, below the $(0.03) consensus estimate. The stock also trades below its 50-day and 200-day moving averages, reflecting continued investor caution.

About Health In Tech

Health In Tech, Inc is a United States-based insurance technology company that provides a digital platform for the self-funded health benefits market. Its technology is designed to connect employers, insurance brokers, third-party administrators, and insurance carriers through a streamlined process for evaluating, selecting, and administering health benefit plans.

The company’s platform supports activities such as plan quoting, proposal management, enrollment, benefits administration, and ongoing communication among participants in the insurance process.